AliveCor will integrate its artificial intelligence technology with the Mayo Clinic's patented algorithms under a partnership that seeks to create tools for long QT syndrome screening and prevention of sudden cardiac death. Under the collaboration, screening techniques and methods will be developed for AliveCor's Kardia Mobile device to facilitate new preventive medicine approaches for patients with LQTS.
AliveCor teams up with Mayo Clinic on long QT syndrome screening
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.